Withdrawn study sought to boost cancer treatment with extra drug
NCT ID NCT01326468
Summary
This study aimed to see if adding a drug called temsirolimus (Torisel) to standard chemotherapy and radiation was safe for people with advanced head and neck cancer. It was designed to find the highest dose of temsirolimus that could be given safely alongside the usual treatments. The trial was withdrawn before any patients were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.